NIH-funded research NIH-funded research

Developing new treatments for opioid withdrawal symptoms

Official title: The development of delta opioid receptor agonists for the treatment of opioid withdrawal associated behaviors

Funded at Washington University · NIH-10730457 · Data updated 2026-11-12

This study is looking for new medications that can help people who are going through opioid withdrawal by easing their pain and withdrawal symptoms, making it easier for them to stay off opioids.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startNovember 1, 2022
Project endOctober 31, 2025
Funding year2022
Award (this year)$2,316,866
NIH project number7UG3DA053094-02
Project IDNIH-10730457 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals who have developed opioid-induced hyperalgesia and are undergoing or considering opioid cessation.

Less likely to help

Patients who are not experiencing opioid withdrawal or opioid-induced hyperalgesia may not benefit from this research.

What this research studies

This research focuses on creating new medications that target delta opioid receptors to help manage symptoms associated with opioid withdrawal and opioid-induced hyperalgesia (OIH). Currently, patients undergoing opioid cessation experience increased pain sensitivity and withdrawal symptoms, leading to a high risk of relapse. The research team will evaluate novel compounds that have shown promise in preclinical models for their ability to alleviate these symptoms without causing adverse effects like seizures. By collaborating with industry partners, the goal is to advance these compounds into clinical testing for potential use in patients suffering from opioid withdrawal.

Why it matters

Potential benefit: If successful, this research could provide a safer and more effective treatment option for patients experiencing opioid withdrawal and related pain sensitivity.

How similar studies have gone: Previous research has shown promise in using biased delta opioid receptor agonists for pain management, indicating potential success for this approach.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Pradhan, Amynah Amir Ali — Washington University
  • Study coordinator: Pradhan, Amynah Amir Ali

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.